Institute of Interdisciplinary Integrative Medicine Research, Shanghai University of Traditional Chinese Medicine, Shanghai, China.
Experimental Research Center, China Academy of Chinese Medical Sciences, Beijing Key Laboratory of Research of Chinese Medicine on Prevention and Treatment for Major Diseases, Beijing, China.
PLoS One. 2024 Feb 16;19(2):e0298148. doi: 10.1371/journal.pone.0298148. eCollection 2024.
Sanhua decoction (SHD), a traditional prescription, has long been used in treating ischemic stroke (IS). However, the therapeutic effect of SHD and the associated changes in gut microbiota and short-chain fatty acids (SCFAs) are uncertain. In this study, a rat model of IS was established by the middle cerebral artery occlusion (MCAO). By evaluating the cerebral infarct area and brain tissue pathology, it was found that SHD ameliorated IS-related symptoms in MCAO rats. Using 16S rRNA gene sequencing, we found that SHD reduced abnormally elevated Lactobacillus and opportunistic pathogens such as Desulfovibrio, but increased some beneficial bacteria that produce SCFAs, including Clostridia, Lachnospiraceae, Ruminococcaceae, and Coprococcus. KEGG analysis revealed that SHD regulates several pathways, including D-arginine and D-ornithine metabolism, polyketide sugar unit biosynthesis, and cyanoamino acid metabolism, which are significantly altered in MCAO rats. By gas chromatography-mass spectrometry detection of SCFAs, we found that fecal acetic acid, valeric acid, and caproic acid were significantly increased in MCAO rats, whereas propionic acid and isobutyric acid were decreased. SHD reversed the changes in acetic acid and propionic acid in the model rats and significantly increased fecal butyric acid. In addition, MCAO rats had significantly higher serum levels of acetic acid, butyric acid, isovaleric acid, and valeric acid, and lower levels of caproic acid. Altered serum levels of butyric acid, isovaleric acid, valeric acid, and caproic acid were restored, and the level of isobutyric acid was reduced after SHD administration. Spearman analysis revealed that cerebral infarct area had a strong correlation with Bifidobacterium, Desulfovibrio, Lachnospiraceae, Lactobacillus, acetic acid, valeric acid, and caproic acid. Overall, this study demonstrates for the first time that the effect of SHD on IS may be related to gut microbiota and SCFAs, providing a potential scientific explanation for the ameliorative effect of SHD on IS.
三花汤(SHD)是一种传统的方剂,长期以来一直用于治疗缺血性中风(IS)。然而,SHD 的治疗效果以及相关的肠道微生物群和短链脂肪酸(SCFAs)的变化尚不确定。在这项研究中,通过大脑中动脉闭塞(MCAO)建立了 IS 大鼠模型。通过评估脑梗死面积和脑组织病理学,发现 SHD 改善了 MCAO 大鼠的 IS 相关症状。通过 16S rRNA 基因测序,我们发现 SHD 降低了异常升高的乳杆菌和机会性病原体,如脱硫弧菌,但增加了一些产生 SCFAs 的有益细菌,包括梭菌、lachnospiraceae、瘤胃球菌科和粪球菌。KEGG 分析显示,SHD 调节了几个途径,包括 D-精氨酸和 D-鸟氨酸代谢、聚酮糖单位生物合成和氰基氨基酸代谢,这些途径在 MCAO 大鼠中发生了显著改变。通过气相色谱-质谱法检测 SCFAs,我们发现 MCAO 大鼠粪便中的乙酸、戊酸和己酸明显增加,而丙酸和异丁酸减少。SHD 逆转了模型大鼠中乙酸和丙酸的变化,并显著增加了粪便中的丁酸。此外,MCAO 大鼠的血清中乙酸、丁酸、异戊酸和戊酸水平明显升高,而己酸水平降低。经 SHD 给药后,血清中丁酸、异戊酸、戊酸和己酸的改变得到恢复,异丁酸水平降低。Spearman 分析显示,脑梗死面积与双歧杆菌、脱硫弧菌、lachnospiraceae、乳杆菌、乙酸、戊酸和己酸有很强的相关性。总的来说,这项研究首次表明,SHD 对 IS 的影响可能与肠道微生物群和 SCFAs 有关,为 SHD 对 IS 的改善作用提供了潜在的科学解释。